Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.90%256.3B | 41.28%1.01T | 58.10%239.76B | 21.21%712.72B | 60.42%231.98B | 6.16%171.65B | 8.34%157.44B | 11.20%151.65B | 16.75%587.98B | 18.52%144.61B |
| Cost of revenue | 6.50%225.1B | 41.40%881.18B | 59.13%211.37B | 19.89%623.18B | 60.82%202.79B | 6.10%149.96B | 5.98%137.61B | 8.42%132.83B | 14.66%519.79B | 15.26%126.1B |
| Gross profit | 9.86%31.19B | 40.43%125.74B | 50.82%28.39B | 31.30%89.54B | 57.73%29.19B | 6.58%21.69B | 28.17%19.83B | 35.78%18.83B | 35.53%68.19B | 46.85%18.51B |
| Operating expense | 6.48%27.71B | 45.42%109.95B | 67.29%26.03B | 33.56%75.61B | 64.98%25.56B | 12.36%18B | 23.27%16.5B | 32.74%15.56B | 30.35%56.61B | 38.52%15.49B |
| Staff costs | ---- | 25.32%24.64B | ---- | 23.96%19.66B | ---- | ---- | ---- | ---- | 21.18%15.86B | ---- |
| Selling and administrative expenses | ---- | 75.12%39.48B | ---- | 31.20%22.55B | ---- | ---- | ---- | ---- | 10.98%17.19B | ---- |
| -General and administrative expense | ---- | 75.12%39.48B | ---- | 31.20%22.55B | ---- | ---- | ---- | ---- | 10.98%17.19B | ---- |
| Depreciation and amortization | ---- | 36.15%2.05B | ---- | 53.27%1.5B | ---- | ---- | ---- | ---- | 34.43%980M | ---- |
| -Depreciation | ---- | 36.15%2.05B | ---- | 53.27%1.5B | ---- | ---- | ---- | ---- | 34.43%980M | ---- |
| Other operating expenses | ---- | 37.25%43.78B | ---- | 41.23%31.9B | ---- | ---- | ---- | ---- | 59.87%22.59B | ---- |
| Operating profit | 47.02%3.48B | 13.37%15.79B | -27.57%2.37B | 20.25%13.92B | 20.46%3.63B | -14.77%3.69B | 59.61%3.33B | 52.43%3.27B | 68.25%11.58B | 112.54%3.02B |
| Net non-operating interest income (expenses) | -115.56%-194M | -122.92%-642M | -742.86%-90M | -9,500.00%-288M | -1,484.62%-206M | -581.82%-53M | -72.00%-43M | -41.67%14M | -110.71%-3M | -154.17%-13M |
| Non-operating interest income | 22.33%126M | 40.08%367M | 35.53%103M | 21.86%262M | 28.57%63M | 15.94%80M | 48.28%43M | 11.76%76M | 8.04%215M | -26.87%49M |
| Non-operating interest expense | 65.80%320M | 110.21%1.01B | 211.29%193M | 120.18%480M | 220.97%199M | 129.31%133M | 59.26%86M | 40.91%62M | 27.49%218M | 44.19%62M |
| Total other finance cost | ---- | ---- | ---- | --70M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -177.61%-156M | 201M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 183.97%886M | 0 | 1,148.00%312M | 2,857.14%207M | 0 | 0 | 483.33%105M | 457.14%25M | 133.33%7M | |
| Income from associates and other participating interests | 47.37%-30M | 719.05%1.2B | -435.29%-57M | 635.00%147M | -9.80%46M | 308.33%98M | 60.00%-14M | 185.00%17M | -83.47%20M | -26.09%51M |
| Special income (charges) | 111.43%4M | -312.39%-1.22B | -148.61%-35M | -57.11%573M | 118.27%454M | 560.00%33M | 125.00%14M | -93.89%72M | -61.03%1.34B | -93.74%208M |
| Less:Restructuring and mergern&acquisition | ---- | ---95M | ---- | --0 | --0 | ---- | ---- | --0 | 54.47%-56M | --0 |
| Less:Other special charges | -325.00%-9M | 109.31%91M | 104.30%4M | 40.82%-977M | -141.95%-796M | -4,800.00%-47M | 64.96%-41M | 92.29%-93M | 54.28%-1.65B | 90.72%-329M |
| Less:Write off | -83.87%5M | 202.23%1.22B | 47.62%31M | 8.89%404M | 182.64%342M | -41.67%14M | -84.39%27M | -60.38%21M | 21.24%371M | -45.98%121M |
| Other non-operating income (expenses) | 13.86%419M | 27.85%1.36B | 56.60%368M | 37.34%1.06B | 157.08%545M | -59.83%92M | 21.66%191M | 33.52%235M | -7.08%774M | 31.68%212M |
| Income before tax | 27.81%3.52B | 10.46%17.37B | -25.81%2.75B | 14.54%15.73B | 34.28%4.67B | -16.08%3.86B | 63.46%3.48B | 5.45%3.71B | 21.70%13.73B | -30.33%3.48B |
| Income tax | 24.43%1.92B | 30.30%8.23B | 8.13%1.54B | 14.35%6.31B | 24.32%1.6B | -0.35%1.71B | 43.72%1.58B | 0.42%1.43B | 27.07%5.52B | -27.06%1.28B |
| Net income | 32.15%1.6B | -2.86%9.15B | -47.02%1.21B | 14.68%9.41B | 40.21%3.08B | -25.49%2.15B | 84.48%1.9B | 8.87%2.28B | 18.34%8.21B | -32.12%2.2B |
| Net income continuous operations | 32.12%1.6B | -2.85%9.15B | -47.00%1.21B | 14.67%9.41B | 40.10%3.08B | -25.46%2.15B | 84.48%1.9B | 8.86%2.29B | 18.33%8.21B | -32.11%2.2B |
| Noncontrolling interests | -47.22%133M | -36.78%605M | 103.23%252M | 180.65%957M | 524.73%581M | 52.27%134M | 174.42%118M | 5.98%124M | 58.60%341M | 190.63%93M |
| Net income attributable to the company | 53.03%1.47B | 0.99%8.54B | -55.63%958M | 7.47%8.46B | 18.73%2.5B | -27.94%2.01B | 80.67%1.79B | 8.99%2.16B | 17.07%7.87B | -34.31%2.1B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 53.03%1.47B | 0.99%8.54B | -55.63%958M | 7.47%8.46B | 18.73%2.5B | -27.94%2.01B | 80.67%1.79B | 8.99%2.16B | 17.07%7.87B | -34.31%2.1B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 52.79%52.88 | -11.25%308.19 | -62.03%34.61 | 4.42%347.26 | 7.71%95.7 | -28.06%85.03 | 80.53%75.37 | 8.82%91.16 | 17.19%332.57 | -34.30%88.85 |
| Diluted earnings per share | 52.79%52.88 | -11.25%308.19 | -62.03%34.61 | 4.42%347.26 | 1.57%90.2247 | -27.94%85.0276 | 80.67%75.359 | 8.82%91.16 | 17.19%332.57 | -34.31%88.8265 |
| Dividend per share | 0 | 16.67%70 | 0 | 20.00%60 | 20.00%60 | 0 | 0 | 0 | 25.00%50 | 25.00%50 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |